Unbound MEDLINE

Rifampin-Associated Pseudomembranous Colitis. The American journal of the medical sciences [Am J Med Sci] Journal article

 
Chen TC, Lu PL, Lin WR, Lin CY, Wu JY, Chen YH 
Rifampin-Associated Pseudomembranous Colitis. [JOURNAL ARTICLE]
Am J Med Sci 2009 Jun 25.


Pseudomembranous colitis (PMC) is known to develop after antibiotic treatment, but is rarely associated with antituberculosis (anti-TB) agents. We report a 28-year-old woman without underlying diseases developing PMC after 126 days of anti-TB treatment. Severe diarrhea and abdominal cramping pain were experienced. Colonoscopic biopsy proved the diagnosis of PMC. Her symptoms improved after discontinuing the anti-TB agents but recurred shortly after challenging with rifampin and isoniazid. Metronidazole administration and replacement of rifampin with levofloxacin successfully cured the PMC. Our report supports the notion that rifampin can induce PMC.



More from this journal
  
Advertise on this site.